November 21, 2025 · Form 4 insider transaction
Huntsman Carole sold 120 shares of Madrigal Pharmaceuticals, Inc. at $548.71 per share, a transaction worth $65.8K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 0 days after the transaction.
These sales were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 5, 2024.; The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $548.25 to $548.94, inclusive.